Literature DB >> 19008550

Molecular cloning of hamster lipid transfer inhibitor protein (apolipoprotein F) and regulation of its expression by hyperlipidemia.

Lahoucine Izem1, Richard E Morton.   

Abstract

Lipid transfer inhibitor protein (LTIP) is a regulator of cholesteryl ester transfer protein (CETP) function. Factors affecting plasma LTIP levels are poorly understood. In humans, plasma LTIP is elevated in hypercholesterolemia. To define possible mechanisms by which hyperlipidemia modifies LTIP, we investigated the effects of hypercholesterolemic diets on plasma LTIP and mRNA levels in experimental animals. The hamster, which naturally expresses CETP, was shown to express LTIP. Hamster LTIP mRNA, exclusively detected in the liver, defined a predicted LTIP protein that is 69% homologous to human, with an isoelectric point of 4.15 and Mr = approximately 16.4 kDa. Hyperlipidemia induced by feeding hydrogenated coconut oil, cholesterol, or both lipids increased plasma LTIP mass up to 2.5-fold, with LTIP mass correlating strongly with plasma cholesterol levels. CETP mass was similarly affected by these diets. In contrast, these diets reduced LTIP hepatic mRNA levels by >50%, whereas CETP mRNA was increased. Similar results for both CETP and LTIP were also observed in cholesterol-fed rabbits. In conclusion, we report in hamster and rabbit that dietary lipids regulate LTIP. Diet-induced hypercholesterolemia markedly increased plasma LTIP mass while concomitantly depressing LTIP gene expression. CETP and LTIP have distinct responses to dietary lipids.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19008550      PMCID: PMC2656661          DOI: 10.1194/jlr.M800429-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  28 in total

1.  Cholesteryl ester exchange protein in human plasma isolation and characterization.

Authors:  N M Pattnaik; A Montes; L B Hughes; D B Zilversmit
Journal:  Biochim Biophys Acta       Date:  1978-09-28

2.  Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element.

Authors:  Y Luo; A R Tall
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

3.  Markedly elevated lipid transfer inhibitor protein in hypercholesterolemic subjects is mitigated by plasma triglyceride levels.

Authors:  R E Morton; V Nunes; L Izem; E Quintão
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-10       Impact factor: 8.311

4.  Purification and characterization of human plasma proteins that inhibit lipid transfer activities.

Authors:  Y S Son; D B Zilversmit
Journal:  Biochim Biophys Acta       Date:  1984-10-04

5.  A plasma inhibitor of triglyceride and cholesteryl ester transfer activities.

Authors:  R E Morton; D B Zilversmit
Journal:  J Biol Chem       Date:  1981-12-10       Impact factor: 5.157

6.  Accelerated transfer of cholesteryl esters in dyslipidemic plasma. Role of cholesteryl ester transfer protein.

Authors:  A Tall; E Granot; R Brocia; I Tabas; C Hesler; K Williams; M Denke
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

7.  Control of cholesteryl ester transfer protein activity by sequestration of lipid transfer inhibitor protein in an inactive complex.

Authors:  Yubin He; Diane J Greene; Michael Kinter; Richard E Morton
Journal:  J Lipid Res       Date:  2008-03-27       Impact factor: 5.922

8.  Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions.

Authors:  M Burstein; H R Scholnick; R Morfin
Journal:  J Lipid Res       Date:  1970-11       Impact factor: 5.922

9.  The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia.

Authors:  Greetje J de Grooth; Tineke J Smilde; Sanne Van Wissen; Anke H E M Klerkx; Aeilko H Zwinderman; Jean-Charles Fruchart; John J P Kastelein; Anton F H Stalenhoef; Jan Albert Kuivenhoven
Journal:  Atherosclerosis       Date:  2004-04       Impact factor: 5.162

10.  Lipid transfer inhibitor protein defines the participation of high density lipoprotein subfractions in lipid transfer reactions mediated by cholesterol ester transfer protein (CETP).

Authors:  Viktor M Paromov; Richard E Morton
Journal:  J Biol Chem       Date:  2003-08-07       Impact factor: 5.157

View more
  8 in total

1.  The lipid transfer properties of CETP define the concentration and composition of plasma lipoproteins.

Authors:  Richard E Morton; Yan Liu
Journal:  J Lipid Res       Date:  2020-06-26       Impact factor: 5.922

2.  Apolipoprotein F: a natural inhibitor of cholesteryl ester transfer protein and a key regulator of lipoprotein metabolism.

Authors:  Yan Liu; Richard E Morton
Journal:  Curr Opin Lipidol       Date:  2020-08       Impact factor: 4.776

3.  ApoF knockdown increases cholesteryl ester transfer to LDL and impairs cholesterol clearance in fat-fed hamsters.

Authors:  Richard E Morton; Yan Liu; Lahoucine Izem
Journal:  J Lipid Res       Date:  2019-09-11       Impact factor: 5.922

4.  Identification of a hormone response element that mediates suppression of APOF by LXR and PPARα agonists.

Authors:  Yan Liu; Lahoucine Izem; Richard E Morton
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-12-06       Impact factor: 4.698

5.  Influence of maternal hypercholesterolemia and phytosterol intervention during gestation and lactation on dyslipidemia and hepatic lipid metabolism in offspring of Syrian golden hamsters.

Authors:  Jie Liu; Aadil Iqbal; Amy Raslawsky; Richard W Browne; Mulchand S Patel; Todd C Rideout
Journal:  Mol Nutr Food Res       Date:  2016-06-23       Impact factor: 5.914

6.  Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease.

Authors:  Robert N Helsley; Venkateshwari Varadharajan; Amanda L Brown; Anthony D Gromovsky; Rebecca C Schugar; Iyappan Ramachandiran; Kevin Fung; Mohammad Nasser Kabbany; Rakhee Banerjee; Chase K Neumann; Chelsea Finney; Preeti Pathak; Danny Orabi; Lucas J Osborn; William Massey; Renliang Zhang; Anagha Kadam; Brian E Sansbury; Calvin Pan; Jessica Sacks; Richard G Lee; Rosanne M Crooke; Mark J Graham; Madeleine E Lemieux; Valentin Gogonea; John P Kirwan; Daniela S Allende; Mete Civelek; Paul L Fox; Lawrence L Rudel; Aldons J Lusis; Matthew Spite; J Mark Brown
Journal:  Elife       Date:  2019-10-17       Impact factor: 8.140

7.  The effects of apolipoprotein F deficiency on high density lipoprotein cholesterol metabolism in mice.

Authors:  William R Lagor; David W Fields; Sumeet A Khetarpal; Arthi Kumaravel; Wen Lin; Nathaniel Weintraub; Kaijin Wu; Sarah F Hamm-Alvarez; Denise Drazul-Schrader; Margarita de la Llera-Moya; George H Rothblat; Daniel J Rader
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

8.  Apolipoprotein F concentration, activity, and the properties of LDL controlling ApoF activation in hyperlipidemic plasma.

Authors:  Richard E Morton; Daniel Mihna
Journal:  J Lipid Res       Date:  2022-01-08       Impact factor: 5.922

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.